Drugs & Targets FDA approves expanded use of Casgevy for pediatric sickle cell disease or transfusion-dependent beta thalassemia July 02, 2026Vol.52 No.26
Podcast Breaking down Operation Trailblazer: Rolling INDs, outside expert submission help, and one-trial requirement July 01, 2026
Cancer Policy FDA advisory panel recommends first-of-its-kind mRNA flu vaccine for older adults June 26, 2026Vol.52 No.25By Claire Marie Porter
Podcast Policy by way of podcaster—FDA issues priority vouchers after Joe Rogan episode on psychedelics June 24, 2026
Regulatory News Is psilocybin heading to a cancer clinic near you?Reversing Nixon-era taboo, Trump orders FDA to fast-track psychedelics and ARPA-H to fund research June 18, 2026Vol.52 No.24By Sara Willa Ernst
News Analysis FDA clears a way for dramatic reduction in animal toxicology studies in cancer June 18, 2026Vol.52 No.24By Claire Marie Porter
Drugs & Targets FDA approves Ambelvist for contrast-enhanced MRI to detect and visualize lesions with abnormal vascularity June 18, 2026Vol.52 No.24
Drugs & Targets FDA accepts sBLA for atezolizumab for patients with stage 3 dMMR colon cancer June 18, 2026Vol.52 No.24
Drugs & Targets FDA warns providers about shortage of breast biopsy needles June 18, 2026Vol.52 No.24
